Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2009
10/08/2009US20090253644 Radiosensitizer
10/08/2009US20090253640 Inhibitors of polyisoprenylated methylated protein methyl esterase
10/08/2009US20090253635 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
10/08/2009US20090253616 Combination therapy for the treatment of cancer
10/08/2009US20090253175 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments
10/08/2009US20090252810 Aryl/alkyl Succinic Anhydride-Hyaluronan Derivatives
10/08/2009US20090252803 Glycyrrhetinic acid-mediated nanoparticles of hepatic targeted drug delivery system, process for preparing the same and use thereof
10/08/2009US20090252761 Papilloma virus vaccine
10/08/2009US20090252752 Kdr peptides and vaccines comprising the same
10/08/2009US20090252747 Immunization; used to elicit a humoral or cellular immune response
10/08/2009US20090252744 Methods for Treating Bone Cancer Pain by Administering A Nerve Growth Factor Antagonist antibody
10/08/2009US20090252743 Antibody for use in the treatment of crohn's and inflammatory diseases such as ankylosing spondylitis; human tumor necrosis factor alpha (TNF) inhibitors
10/08/2009US20090252738 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
10/08/2009US20090252737 T Cell Regulatory Genes And Methods Of Use Thereof
10/08/2009US20090252735 Novel Peptides for Development of Diagnostic and Therapeutic Agents and Methods of Using Same
10/08/2009US20090252734 Antihuman alpha 9 Integrin Antibody and use of the Same
10/08/2009US20090252733 Generation and Profiling of Fully Human Gold-Derived Therapeutic Antibodies Specific for Human CD38
10/08/2009US20090252731 Multivalent Carriers of Bi-Specific Antibodies
10/08/2009US20090252728 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
10/08/2009US20090252721 Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer
10/08/2009US20090252716 Methods for identifying nuclear receptor/ligand combinations for targeting brain tumor stem cells and for their use
10/08/2009US20090252706 Tetrahydropyridothiophenes As Antripoliferative Agents For The Treatment Of Cancer
10/08/2009US20090252702 Polymer-based anti-cancer agents
10/08/2009US20090252694 Novel Chalcone Derivatives, Pharmaceutically Acceptable Salt, Method for Preparation and Uses Thereof
10/08/2009US20090252684 Determination of tissue-specific profile of amino acid requirements form the relationship between the amounts of tRNAs for individual amino acids and the protein-bound amino acid profile of the tissue
10/08/2009US20090252683 Composition Comprising Cross-Species-Sepecific Antibodies and uses Thereof
10/08/2009US20090252681 Nanobodies and Polypeptides Against EGFR and IGF-IR
10/08/2009US20090252677 Probes for In Vivo Targeting of Active Cysteine Proteases
10/08/2009US20090252675 Radionuclide Therapy for Urinary Bladder Cancer
10/08/2009US20090252674 Tripodal Ligands with the Coordinating Motifs K2 -BH2 or K3 -BH3 Relevant for Biomedical Applications of Organometallic Complexes
10/08/2009CA2720632A1 Halichondrin b analogs
10/08/2009CA2720473A1 Compositions and use of epas1 inhibitors
10/08/2009CA2720390A1 Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents
10/08/2009CA2720359A1 Liver cancer drug
10/08/2009CA2720350A1 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling
10/08/2009CA2720343A1 Heterocyclic derivative and use thereof
10/08/2009CA2720294A1 Assay for soluble cd200
10/08/2009CA2720183A1 Liquid and freeze dried formulations
10/08/2009CA2720164A1 Processes for preparing sunitinib and salts thereof
10/08/2009CA2720037A1 Purine derivatives as a3 adenosine receptor-selective agonists
10/08/2009CA2720025A1 Novel antibodies against cancer target block tumor growth, angiogenesis and metastasis
10/08/2009CA2720011A1 C-aryl glycoside compounds for the treatment of diabetes and obesity
10/08/2009CA2719964A1 Partial peptide of survivin presented on mhc class ii molecule and use thereof
10/08/2009CA2719362A1 Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors
10/08/2009CA2719216A1 Compositions and methods for treatment of neoplastic disease
10/08/2009CA2719032A1 Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use
10/08/2009CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/07/2009EP2107115A1 Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2
10/07/2009EP2107071A2 Anti-EpCAM immunoglobulins
10/07/2009EP2106807A1 Compositions and kits for enhancing delivery of therapeutic agents to cells
10/07/2009EP2106806A1 Nanoparticles for targeted delivery of active agents to the lung
10/07/2009EP2106804A2 Composition and method for detection of pre-metastatic sites
10/07/2009EP2106800A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
10/07/2009EP2106795A1 Use of phthalide dipolymers for antitumor
10/07/2009EP2106793A1 Ready to use Oxaliplatin solutions
10/07/2009EP2106788A1 Liquid and freeze dried formulations
10/07/2009EP2106442A1 Cancerous disease modifying antibodies
10/07/2009EP2106441A1 Cancerous disease modifying antibodies
10/07/2009EP2106399A2 Imidazole derivatives as kinesin spindle protein inhibitors (eg-5)
10/07/2009EP2106212A2 Nuclear receptor binding agents
10/07/2009EP1719509B1 Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiogenesisdependent diseases such as cancer and psoriasis
10/07/2009EP1617216B1 Novel method of screening
10/07/2009EP1584627B1 Dimerized peptide
10/07/2009EP1505075B1 Antibody to human insulin-like growth factor
10/07/2009EP1434791B1 Specific binding agents of human angiopoietin-2
10/07/2009EP1248774B1 Polyhydroxystilbenes and stilbene oxides as antipsoriatic agents and protein kinase inhibitors
10/07/2009EP1235595B8 Integrin-mediated drug targeting
10/07/2009EP0572557B1 Use of topotecan in the manufacture of a medicament for use in the treatment of ovarian cancer
10/07/2009CN101553728A The use of Granulin-Epithelin Precursor (GEP) antibodies for detection and suppression of Hepatocellular carcinoma (HCC)
10/07/2009CN101553500A GnRH peptide derivative (gonadotropin-releasing hormone)
10/07/2009CN101553492A RAF inhibitor compounds and methods of use thereof
10/07/2009CN101553490A Bicyclic triazoles as protein kinase modulators
10/07/2009CN101553484A Thrombin receptor antagonists based on the modified tricyclic unit of himbacine
10/07/2009CN101553476A Mitotic kinesin inhibitors and methods of use thereof
10/07/2009CN101553473A Substituted pyrazoles, compositions containing these, method of production and use
10/07/2009CN101553282A 2-{[2-(substituted amino)ethyl]sulfonyl}ethyl n,n,n',n'-tetrakis(2-chloroethyl)phosphorodiamidates
10/07/2009CN101553259A Cytotoxicity mediation of cells evidencing surface expression of CD63
10/07/2009CN101553223A Combination of an HDAC inhibitor and an antimetabolite
10/07/2009CN101553137A Apples with high polyphenolic content
10/07/2009CN101550416A Humanized single anti-Hu-ScFv18 light and heavy chain variable region gene and coding polypeptide thereof and application thereof
10/07/2009CN101550415A Analogue of micro RNA-181a precursor and uses thereof
10/07/2009CN101550193A Novel IZ-shGITRL fusion protein and preparation method and application thereof
10/07/2009CN101550191A Malignant melanoma T cell nano antibody, coding sequence and application thereof
10/07/2009CN101550185A New tumor-related gene or protein and application thereof
10/07/2009CN101550184A Marking protein on tumor drug-resistant film surface and application thereof as drug-resistant tumor drug target protein
10/07/2009CN101550177A Effective component of radix pulsatillae and preparation method thereof
10/07/2009CN101550162A Fostriecin derivant and medicinal use thereof
10/07/2009CN101550161A Andrographolide derivative, salt, preparation method and application thereof
10/07/2009CN101550159A A chiral bithioureido derivate containing phosphonate as well as its preparing method and use
10/07/2009CN101550136A Diarylurea derivatives and application thereof used for preparing anti-neoplastic medicament
10/07/2009CN101550120A Effective component of artemisia leaves and preparation method thereof
10/07/2009CN101550114A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
10/07/2009CN101550109A Design and synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs
10/07/2009CN101550098A 4-isothio-urea-butyronitrile hydrochloride and application of derivatives thereof
10/07/2009CN101550081A Effective components of Cacumen Platycladi and preparation method thereof
10/07/2009CN101549158A Sodium alginate liver-targeted nanometer drug delivery system and preparing method thereof
10/07/2009CN101549153A Composite and method for self-treating tumor
10/07/2009CN101549135A Drug for preventing and treating tumor and cancer
10/07/2009CN101549117A Bagasse (leaf) extract with anti-tumor effect and its application
10/07/2009CN101549111A Effective component of cogongrass rhizome and preparation method thereof
1 ... 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 ... 2211